Начало › Рак на белия дроб › Вирджиния › Arlington
Клинични проучвания за Рак на белия дроб в Arlington, VA
41 проучвания за Рак на белия дроб търсят участници в обекти в и около Arlington (в радиус от около 30 мили). Отворете проучването, за да видите кой може да участва и как да се свържете с екипа.
Официален текст на проучването (английски)
Търсите участници за проучване? Представяме го в началото на тази страница — $99 за 30 дни →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Набиране на участнициФаза 3
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 мили
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)
Набиране на участнициФаза 2
- Virginia Cancer Specialists (VCS) ( Site 0408), Fairfax · на 11 мили
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of PHN-012 in Patients With Advanced Solid Tumors
Набиране на участнициФаза 1
- PHN-012-001 Site, Fairfax · на 11 мили
Phase 1 Study of PF-08046033 in Advanced Solid Tumors
Набиране на участнициФаза 1
- Inova Schar Cancer Infusion Pharmacy, Fairfax · на 11 мили
- Inova Schar Cancer, Fairfax · на 11 мили
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Набиране на участнициФаза 2
- Research Site, Fairfax · на 11 мили
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Набиране на участнициФаза 2/3
- Virginia Cancer Specialists - Arlington, Arlington
- Virginia Cancer Specialists, Fairfax · на 11 мили
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Набиране на участнициФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 мили
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
Набиране на участнициФаза 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · на 11 мили
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Набиране на участнициФаза 1
- NEXT - Virginia, Fairfax · на 11 мили
BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 мили
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Набиране на участнициФаза 1
- Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Набиране на участнициФаза 3
- USO - Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- USO-Virginia Cancer Specialists, PC, Fairfax · на 11 мили
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Набиране на участнициФаза 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · на 11 мили
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Набиране на участнициФаза 1
- NEXT Oncology, Fairfax · на 11 мили
The Vanguard Study: Testing a New Way to Screen for Cancer
Набиране на участнициЗдравите доброволци са добре дошли
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- Inova Fair Oaks Hospital, Fairfax · на 11 мили
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 мили
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
Набиране на участнициФаза 3
- Virginia Cancer Specialists, Fairfax · на 11 мили
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Набиране на участнициФаза 3
- Inova Schar Cancer Institute, Fairfax · на 11 мили
- Inova Fair Oaks Hospital, Fairfax · на 11 мили
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · на 11 мили
A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Набиране на участнициФаза 1/2
- NEXT Oncology Virginia, Fairfax · на 11 мили
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Набиране на участнициФаза 1
- Research Site, Fairfax · на 11 мили
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 мили
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Набиране на участнициФаза 1
- NEXT Oncology Virginia, Fairfax · на 11 мили
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Набиране на участнициФаза 1/2
- Next Oncology Virginia, Fairfax · на 11 мили
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
Набиране на участнициФаза 1/2
- NEXT Oncology, Fairfax · на 11 мили
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 мили
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Набиране на участнициФаза 2/3
- Kaiser Permanente Tysons Corner Medical Center, McLean · на 5 мили
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Набиране на участнициФаза 2
- Inova Fairfax Hospital, Fairfax · на 11 мили
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Набиране на участнициФаза 1/2
- NEXT Virginia, Fairfax · на 11 мили
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Набиране на участнициФаза 1
- NEXT Virginia, Fairfax · на 11 мили
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Набиране на участнициФаза 1/2
- Virginia Cancer Specialists, Fairfax · на 11 мили
Проучвания за Рак на белия дроб в други градове
- Houston, TX78 проучвания
- Boston, MA62 проучвания
- New York City, NY60 проучвания
- Los Angeles, CA45 проучвания
- Washington, DC41 проучвания
- Chicago, IL41 проучвания
- Nashville, TN40 проучвания
- Baltimore, MD40 проучвания
- St. Louis, MO39 проучвания
- Columbus, OH37 проучвания
- Philadelphia, PA36 проучвания
- Seattle, WA33 проучвания
Други проучвания в Arlington
- Рак на белия дроб с недребноклетъчен тип104 проучвания
- Метастатичен рак53 проучвания
- Колоректален рак52 проучвания
- Рак (всички видове)48 проучвания
- Рак на гърдата46 проучвания
- Рак на яйчниците46 проучвания
- Ендометриален рак39 проучвания
- Рак на панкреаса33 проучвания
- Плоскоклетъчен карцином на главата и шията26 проучвания
- Дребноклетъчен белодробен рак23 проучвания
- Тройно негативен рак на гърдата20 проучвания
- Рак на стомаха20 проучвания
От ClinicalTrials.gov, данни към 5.10.2026 г.. Всяко проучване има свои критерии за участие; екипът на проучването определя кой може да се включи.